The Biden Administration is waging a relentless regulatory assault on drug makers, primarily less than media radar. The latest entrance could be the Wellbeing and Human Providers Division’s new “cost transparency” rule that seeks to dun drug makers to pay for Medicaid. This Web page is employing a safety services to protect by itself from